Trade JSPRW stock anytime, 24x5 in Singapore
Regulated by
Monetary Authority of Singapore (MAS)
Trusted by
400,000+ users
Japer Therapeutics, Inc. Warrants (JSPRW) is trading at US$0.01, down 15.38% today as of Sep 15, 10:37 EDT. Over the past 52 weeks, JSPRW has traded between US$0.00 and US$0.15. On Syfe you can trade JSPRW with $0 commission and add it to your watchlist.
| Previous close | US$0.01 |
|---|---|
| 52-week range | US$0.00 – US$0.15 |
| Volume | 12.44K |
| Exchange | US |
Add to Watchlist
Set Price Alert
Japer Therapeutics, Inc. Warrants
Jasper Therapeutics, Inc. is a clinical-stage biotechnology company, which engages in enabling cures through hematopoietic stem cell therapy. It focuses on the development and commercialization of safer, stem cell engineering to allow for expanded use of stem cell transplantation and ex vivo gene therapy, a technique in which genetic manipulation of cells is performed outside of the body prior to transplantation. The company was founded by Judith Shizuru and Susan Prohaska in March 2018 and is headquartered in Redwood City, CA.
Year: 2021
Japer Therapeutics, Inc. Warrants (JSPRW) stock is trading at US$0.01, -15.38% from the previous close of US$0.01.
The 52-week high for Japer Therapeutics, Inc. Warrants (JSPRW) stock is US$0.15.
The 52-week low for Japer Therapeutics, Inc. Warrants (JSPRW) stock is US$0.00.
Japer Therapeutics, Inc. Warrants (JSPRW) does not currently pay a dividend.
Stay on top of JSPRW
Price moves, news and earnings — straight to your inbox.
Est. order value
US$0.00
Snapshot
Popular Stocks in Singapore
